Boragen Inc.

Boragen Inc. specializes in agricultural biotechnology, focusing on developing innovative biopesticides and fungicides that leverage natural compounds to enhance crop protection and improve yields in a sustainable manner. Boragen Inc. is an agricultural biotechnology firm founded in 2017 and headquartered in Durham, US.

The company focuses on developing solutions to combat plant diseases and pests. Its founders, C. Liu, Paul Schimmel, and Stephen Benkovic, have backgrounds in related fields. As of December 2019, Boragen raised USD 2.

00 mn in a venture funding round, totaling USD 2. 00 mn raised overall. The company has engaged in 3 distinct deals since its inception. Boragen Inc.

develops innovative biopesticides and fungicides that utilize natural compounds for crop protection. Their product offerings are designed to address challenges such as resistance to traditional pesticides and the demand for sustainable farming practices, targeting markets in North America and Europe. Boragen Inc. generates revenue through partnerships and direct sales of its agricultural products.

The company employs a subscription model for certain offerings, facilitating ongoing support and updates. Sales agreements with agricultural distributors are common, allowing for bulk purchases to serve crop producers. Pricing for their products is tailored based on type and usage volume, contributing to their revenue from both direct sales and partnerships. Boragen Inc.

aims to expand its product line and market presence. Following its recent funding round in December 2019, where the company raised USD 2. 00 mn, Boragen plans to develop new biopesticides and fungicides, targeting further market reach in North America and Europe. The funds will support the launch of these upcoming products and strengthen its position in sustainable agricultural practices.